Reuters logo
BRIEF-Dimension board determines Ultragenyx’s unsolicited proposal constitutes a “superior proposal”
October 2, 2017 / 12:29 PM / in 15 days

BRIEF-Dimension board determines Ultragenyx’s unsolicited proposal constitutes a “superior proposal”

Oct 2 (Reuters) - Dimension Therapeutics Inc

* Dimension board determines that Ultragenyx’s unsolicited proposal to acquire dimension for $6.00 per share constitutes a “superior proposal”

* Dimension Therapeutics Inc - ‍dimension board has not changed its recommendation in support of REGENXBIO transaction​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below